Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1348078

registered interest
date	19/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent engagement he has had with participants on the Novavax trial.
tabling member constituency	Putney
tabling member printed	Fleur Anderson
uin	35914
answer	answer is ministerial correction date of answer 29/07/2021 answer text <p>Ministers have had no recent engagement with trial participants.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 29/07/2021 15:45:06 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4788 label Biography information for Fleur Anderson

1348100

registered interest
date	19/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support the health and wellbeing needs of people who are currently participating in trials of unapproved covid-19 vaccines.
tabling member constituency	Brent Central
tabling member printed	Dawn Butler
uin	35555
answer	answer is ministerial correction date of answer 28/07/2021 answer text <p>Participants in all clinical trials are provided with contact details at the local site should they have any health and wellbeing concerns which may be related to the trial.</p><p>The trial’s principle investigator advise the participant based on their knowledge of whether the participant received an active COVID-19 vaccine trial product or a placebo.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 28/07/2021 13:36:04 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 16515 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1489 label Biography information for Dawn Butler

1348213

registered interest
date	19/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the Government's guidance is on the number of weeks that should elapse between receipt of the first and second dose of the covid-19 vaccine for pregnant women; and what the evidence is behind that guidance.
tabling member constituency	Richmond Park
tabling member printed	Sarah Olney
uin	35835
answer	answer is ministerial correction date of answer 22/07/2021 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) recommends an interval of eight weeks between doses of all the available COVID-19 vaccines, including for pregnant women. On 14 May 2021, in response to the increasing rates of infection of the Delta variant, the Government amended the interval of second doses for the most vulnerable cohorts who were offered a vaccine in phase one of the programme, from 12 weeks to eight weeks. The eight-week dose interval was applied to all eligible cohorts from 6 July.</p><p>The current evidence shows that a longer dose interval produces a better immune response. As such, the JCVI has advised against reducing the dose interval further in order to maximise the effectiveness of the vaccination programme. The JCVI regularly reviews its advice, taking into account new data and evidence on the effectiveness of the programme and epidemiological situation.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 22/07/2021 15:53:23 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4591 label Biography information for Sarah Olney

1348390

registered interest
date	19/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many pregnant women have received (a) one dose (b) two doses of a covid-19 vaccine in the London Borough of Wandsworth as of 19 July 2021.
tabling member constituency	Battersea
tabling member printed	Marsha De Cordova
uin	35878
answer	answer is ministerial correction date of answer 22/07/2021 answer text <p>This information is not held centrally.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 22/07/2021 15:50:44 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4676 label Biography information for Marsha De Cordova

1348478

registered interest
date	19/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department has made any special arrangements to encourage people living illegally in the UK to receive covid-19 vaccinations in recognition that those people will not have NHS or national insurance numbers and may be fearful of engaging with the covid-19 vaccination programme.
tabling member constituency	Gravesham
tabling member printed	Adam Holloway
uin	35566
answer	answer is ministerial correction date of answer 23/07/2021 answer text <p>Vaccination against COVID-19 is offered to every adult living in the United Kingdom free of charge, regardless of immigration status. Entitlement to free National Health Service treatment is generally based on ordinary residence in the UK. A person who can show they have taken up ordinary residence in the UK can access all NHS services immediately, including COVID-19 vaccinations, based on clinical need. No immigration checks are needed to receive these services and the NHS is not required to report undocumented migrants to the Home Office.</p><p>An NHS number is not needed to make a booking for a COVID-19 vaccine or when attending a vaccination appointment. If individuals are registered with a general practitioner (GP), their GP will contact them in due course. If they are not registered with a GP, NHS regional teams, will contact unregistered people to ensure they are offered the vaccine. The Enhanced Service Specification: COVID-19 vaccination programme 2020/21 enables practices working within their Primary Care Network groupings from shared vaccination sites to vaccinate unregistered patients provided they are eligible.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 23/07/2021 14:11:42 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1522 label Biography information for Adam Holloway

1347623

registered interest
date	16/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that people who took part in covid-19 vaccine trials for products not yet approved are able to (a) certify their vaccine status and (b) access alternative vaccines through the NHS.
tabling member constituency	Blackpool North and Cleveleys
tabling member printed	Paul Maynard
uin	34479
answer	answer is ministerial correction date of answer 22/07/2021 answer text <p>The Government is working with clinical research sites to add participant information of COVID-19 vaccine clinical trials into the National Immunisation Management Service, in order to allow participants to access their NHS COVID Pass for both domestic and international travel purposes.</p><p> </p><p>When a former COVID-19 vaccine clinical trial participant becomes eligible for a vaccine currently in deployment, they may ask for the trial to be unblinded. If they have received two placebo doses, they may freely take up the vaccine doses offered to them. If they have received only one dose and a placebo, or are yet to receive a second dose, they may receive an additional dose of the trialled vaccine if agreed by and available from the clinical trial sponsor or receive a single dose of a vaccine approved and currently in deployment, with the acknowledgement that safety data on the combination of the different vaccine is not yet available. If they have received two doses of the vaccine, they will not need additional doses under current guidance.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 22/07/2021 15:46:02 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	3926 label Biography information for Paul Maynard

1347742

registered interest
date	16/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much (a) his Department and (b) the NHS has spent on (i) advertising using social media and other forms of information channels and (ii) other public information to encourage people to uptake the covid-19 vaccine to date; and how much has been spent on public information to encourage minority communities to receive that vaccination.
tabling member constituency	Reading East
tabling member printed	Matt Rodda
uin	34567
answer	answer is ministerial correction date of answer 26/07/2021 answer text <p>The Department spent £1.3 million on advertising between December 2020 and 31 January 2021. Activity included tailored content designed to specifically support multicultural communities. Some local National Health Service teams ran COVID-19 vaccine campaigns, but this information is not collected centrally.</p><p>Campaign spending supporting the COVID-19 vaccination programme transferred to the Cabinet Office in February 2021.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 26/07/2021 12:30:17 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 16047 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4654 label Biography information for Matt Rodda

1347747

registered interest
date	16/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when his Department plans to offer people who are immunosuppressed, but not identified as extremely clinically vulnerable, a booster covid-19 vaccination as part of the covid-19 vaccination booster programme.
tabling member constituency	Lewisham, Deptford
tabling member printed	Vicky Foxcroft
uin	34548
answer	answer is ministerial correction date of answer 26/07/2021 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) published interim advice on a potential COVID-19 booster vaccination programme on 30 June, which is available at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/uk-5-year-action-plan-for-antimicrobial-resistance-2019-to-2024%20" target="_blank">https://www.gov.uk/government/publications/uk-5-year-action-plan-for-antimicrobial-resistance-2019-to-2024 </a></p><p> </p><p>The JCVI advises a two staged approach, with individuals in stage one offered a booster and flu vaccine as soon as possible from September. Individuals in stage two should be offered a booster vaccine as soon as practicable after stage one, with equal emphasis on deployment of the flu vaccine where eligible. The JCVI suggests that adults aged 16 years old and over who are immunosuppressed are offered a booster vaccine in stage one.</p><p> </p><p>Final decisions on the timing and scope and cohort eligibility of any COVID-19 vaccine booster programme will be confirmed once the JCVI has provided their final advice.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 26/07/2021 16:15:40 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4491 label Biography information for Vicky Foxcroft

1347421

registered interest
date	15/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what comparative assessment he has made of the number of (a) men and (b) women receiving the covid-19 vaccination; and what steps he is taking to ensure that equal numbers of men and women receive that vaccination.
tabling member constituency	Shipley
tabling member printed	Philip Davies
uin	33874
answer	answer is ministerial correction date of answer 29/07/2021 answer text <p>No specific comparative assessment has been made on the number of men and women receiving a COVID-19 vaccine.</p><p>The ‘UK COVID-19 vaccine uptake plan’ published in February sets out the Government’s approach to ensure that all groups have the opportunity to receive the vaccine. The plan is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/covid-19-vaccination-uptake-plan/uk-covid-19-vaccine-uptake-plan" target="_blank">https://www.gov.uk/government/publications/covid-19-vaccination-uptake-plan/uk-covid-19-vaccine-uptake-plan</a></p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 29/07/2021 15:42:22 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1565 label Biography information for Sir Philip Davies

1347476

registered interest
date	15/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he has taken to ensure that young people who (a) will turn 18 in July or August and (b) are going to university in 2021 have been offered both doses of a covid-19 vaccination prior to the commencement of the university new term.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	33971
answer	answer is ministerial correction date of answer 20/07/2021 answer text <p>The Government has accepted the Joint Committee on Vaccination and Immunisation (JCVI) advice that young people, including students, may be offered a COVID-19 vaccination within three months of turning 18 years old. The second dose of the vaccine would be offered eight weeks after the first dose.</p><p>Students over the age of 16 years old with underlying health conditions that put them at risk of serious outcomes from COVID-19 have been offered both doses of vaccine as part of phase one of the vaccine deployment programme. Age is assessed to be the strongest factor linked to mortality, morbidity and hospitalisations.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 33895 33972 question first answered 20/07/2021 15:26:36 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4471 label Biography information for Rachael Maskell